1. Home
  2. T vs JNJ Comparison

T vs JNJ Comparison

Compare T & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AT&T Inc.

T

AT&T Inc.

HOLD

Current Price

$22.36

Market Cap

175.5B

ML Signal

HOLD

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$233.13

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
T
JNJ
Founded
1983
1886
Country
United States
United States
Employees
133030
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.5B
542.4B
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
T
JNJ
Price
$22.36
$233.13
Analyst Decision
Buy
Buy
Analyst Count
20
20
Target Price
$30.55
$238.20
AVG Volume (30 Days)
37.1M
6.4M
Earning Date
04-22-2026
04-14-2026
Dividend Yield
4.31%
2.36%
EPS Growth
N/A
90.50
EPS
N/A
2.14
Revenue
N/A
N/A
Revenue This Year
$4.34
$6.63
Revenue Next Year
$2.14
$7.43
P/E Ratio
$9.14
$110.09
Revenue Growth
N/A
N/A
52 Week Low
$22.32
$149.04
52 Week High
$29.79
$251.71

Technical Indicators

Market Signals
Indicator
T
JNJ
Relative Strength Index (RSI) 31.60 52.32
Support Level N/A $221.66
Resistance Level $26.32 $235.50
Average True Range (ATR) 0.58 4.66
MACD -0.02 0.64
Stochastic Oscillator 3.02 60.65

Price Performance

Historical Comparison
T
JNJ

About T AT&T Inc.

The wireless business contributes nearly 70% of AT&T's revenue. The company is the third-largest US wireless carrier, connecting 74 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 14% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential services, about 11% of revenue, primarily consist of in-home broadband internet access, serving 15 million customers. AT&T also has a sizable presence in Mexico, with 25 million wireless customers, but this business only accounts for 3% of revenue. The company recently sold its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Share on Social Networks: